Global Pharmaceuticals & Biotech Breakout Stocks

Moderna

Market Cap: US$53.2b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

BioNTech

Market Cap: US$28.4b

Engages in the development and commercialization of immunotherapies in Germany.

Genscript Biotech

Market Cap: HK$73.0b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

Amylyx Pharmaceuticals

Market Cap: US$4.3b

A clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States.

Iovance Biotherapeutics

Market Cap: US$4.1b

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.

Walvax Biotechnology

Market Cap: CN¥24.2b

Engages in the research and development, manufacture, and distribution of vaccines in China and internationally.

Maravai LifeSciences Holdings

Market Cap: US$2.2b

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Eton Pharmaceuticals

Market Cap: US$1.8b

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

Basilea Pharmaceutica

Market Cap: CHF 813.6m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Immix Biopharma

Market Cap: US$943.6m

A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.

4D Molecular Therapeutics

Market Cap: US$888.3m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Jenkem Technology

Market Cap: CN¥5.4b

Engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol (PEG), and its derivatives in China and internationally.

Nuvectis Pharma

Market Cap: US$760.1m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

Hunan Hansen Pharmaceutical

Market Cap: CN¥4.7b

Engages in the production and sale of traditional Chinese preparations in China and internationally.

Shanghai Shenqi Pharmaceutical Investment Management

Market Cap: CN¥4.3b

Operates as a pharmaceutical manufacturing holding investment company in China.

OmniAb

Market Cap: US$609.2m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Prelude Therapeutics

Market Cap: US$595.3m

A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.

Xinjiang Tianshan Animal Husbandry Bio-engineering

Market Cap: CN¥3.4b

Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.

Deva Holding

Market Cap: ₺17.8b

Manufactures, markets, and sells pharmaceutical products in Turkey.

Solara Active Pharma Sciences

Market Cap: ₹30.8b

Manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.

AVITA Medical

Market Cap: US$319.8m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

ProQR Therapeutics

Market Cap: US$313.3m

A clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

Acumen Pharmaceuticals

Market Cap: US$227.8m

A clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer’s disease.

Psomagen

Market Cap: ₩72.1b

Engages in the provision omics solutions and contract laboratory services.

Apollomics

Market Cap: US$51.8m

A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.

Bilcare

Market Cap: ₹2.4b

Provides pharmaceutical packaging research solutions in India and internationally.

EOM Pharmaceuticals Holdings

Market Cap: US$16.7m

A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.

Zenith Capital

Market Cap: US$16.0m

A biotechnology investment company, engages in the development of bromodomain inhibitors for the treatment of cancer and other disorders with unmet medical needs.

Aton

Market Cap: €12.8m

Operates as a bioscience company in France.

Brainstorm Cell Therapeutics

Market Cap: US$13.4m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

Hemostemix

Market Cap: CA$15.8m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

Dannex Ayrton Starwin

Market Cap: GH₵89.9m

Engages in the manufacturing, importing, and sale of pharmaceutical products in Ghana.

Nuformix

Market Cap: UK£4.4m

Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.

International Stem Cell

Market Cap: US$4.1m

A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.

Emmaus Life Sciences

Market Cap: US$905.4k

A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.

ObsEva

Market Cap: US$11.7k

A biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health.